Cleared Special

QLAB Advanced Quantification Software 13 (K190913) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K190913 · Philips Health Care · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
71d
Days
Class 2
Risk

K190913 is an FDA 510(k) clearance for the QLAB Advanced Quantification Software 13. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Health Care (Bothell, US). The FDA issued a Cleared decision on June 18, 2019 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Health Care devices

Submission Details

510(k) Number K190913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2019
Decision Date June 18, 2019
Days to Decision 71 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 107d · This submission: 71d
Pathway characteristics
Modification to existing cleared device. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2268
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K190913.
CustoMED Viewer
K260116 · CustoMED , Ltd. · Jun 2026
Helion Viewer Suite
K254265 · Videomed Srl ( a Baxter Healthcare Corp company) · May 2026
CMN Capillary Function with Virtual Expert for MRI, CT and CBCT
K253831 · Cercare Medical A/S · May 2026
SubtleHD-PET (1.x)
K254013 · Subtle Medical, Inc. · May 2026
HipGuide (V 1.0.0.0)
K260321 · Orthopedic Driven Imaging, LLC · May 2026
Neowise
K260716 · Cefla S.C. · May 2026